Chagas disease and mortality in a community-based cohort in Colombia: evidence for age-dependent effect modification
Transactions of The Royal Society of Tropical Medicine and Hygiene · 2026
DOI: 10.1093/trstmh/trag074 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transactions of The Royal Society of Tropical Medicine and Hygiene, 2026. Verfasst von Martha Lucía Díaz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Grupo de Inmunología y Epidemiología Molecular, Universidad Industrial de Santander, Carrera 32 #29-31, 680002 Bucaramanga, Colombia. Hauptthemen laut MEDLINE: Chagas Disease. Die Arbeit nennt 25 Literaturangaben. Gefördert von: Universidad Industrial de Santander, Retos y Agendas de Investigación UIS, Programa estratégico de investigación aplicada interdisciplinar.
Abstract (Originalsprache)
Background
Chagas disease (CD), caused by Trypanosoma cruzi, is a leading cause of cardiomyopathy in Latin America. Community-based prospective data on the CD–mortality association remain scarce.
Methods
We analysed the ANTORCHA prospective cohort, enrolling individuals from T. cruzi-endemic communities in Santander, Colombia (2015–2025). The primary exposure was serologically confirmed CD; the primary outcome was all-cause mortality. Cox proportional hazards models with hierarchical adjustment and restricted mean survival time (RMST) were used.
Results
Among 1509 participants (314 Chagas positive), 81 deaths occurred over a median follow-up of 5.6 y. After full multivariate adjustment, CD was not associated with overall mortality (hazard ratio [HR] 1.02 [95% confidence interval {CI} 0.61 to 1.72]). A significant age-dependent interaction was identified (p=0.007): CD was independently associated with increased mortality among participants <60 y of age (HR 4.96 [95% CI 1.80 to 13.71]) but not among those ≥60 y of age (HR 0.73 [95% CI 0.43 to 1.22]). RMST analysis confirmed an absolute survival loss of 121 d at approximately 10 y of follow-up in the younger subgroup (p=0.02).
Conclusions
In this community-based cohort, CD was independently associated with markedly elevated mortality among adults <60 y of age. Younger T. cruzi-positive individuals warrant intensified cardiovascular surveillance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Grupo de Inmunología y Epidemiología Molecular, Universidad Industrial de Santander, Carrera 32 #29-31, 680002 Bucaramanga, Colombia.
- Research Center, Fundación Cardiovascular de Colombia, Calle 155A No. 23-58 (Urbanización El Bosque), 681003 Floridablanca, Santander, Colombia.
- Heart Failure Center of Excellence, Fundación Cardiovascular de Colombia, Calle 155A No. 23-58 (Urbanización El Bosque), 681003 Floridablanca, Santander, Colombia.
ORCID-Profile: Luis Eduardo Echeverría, Sergio Alejandro Gómez-Ochoa
Förderung
- Universidad Industrial de Santander
- Retos y Agendas de Investigación UIS
- Programa estratégico de investigación aplicada interdisciplinar
- Royal Society of Tropical Medicine and Hygiene
Zitieren
APA
Díaz, M. L., Rojas, L. Z., González-Rugeles, C. I., Echeverría, L. E., & Gómez-Ochoa, S. A. (2026). Chagas disease and mortality in a community-based cohort in Colombia: evidence for age-dependent effect modification. Transactions of The Royal Society of Tropical Medicine and Hygiene. https://doi.org/10.1093/trstmh/trag074
Vancouver
Díaz ML, Rojas LZ, González-Rugeles CI, Echeverría LE, Gómez-Ochoa SA. Chagas disease and mortality in a community-based cohort in Colombia: evidence for age-dependent effect modification. Transactions of The Royal Society of Tropical Medicine and Hygiene. 2026. doi:10.1093/trstmh/trag074
BibTeX
@article{Daz2026,
author = {Díaz, Martha Lucía and Rojas, Lyda Z and González-Rugeles, Clara Isabel and Echeverría, Luis Eduardo and Gómez-Ochoa, Sergio Alejandro},
title = {Chagas disease and mortality in a community-based cohort in Colombia: evidence for age-dependent effect modification},
journal = {Transactions of The Royal Society of Tropical Medicine and Hygiene},
year = {2026},
doi = {10.1093/trstmh/trag074}
}
EUVIMED